| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic … E Gakidou, A Afshin, AA Abajobir, KH Abate, JF van Boven, SS Lim, ... The Lancet 390 (10100), 1345-1422, 2017 | 5560* | 2017 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the … T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, JFM van Boven, ... The Lancet 390 (10100), 1211-1259, 2017 | 5479 | 2017 |
| Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 M Naghavi, AA Abajobir, C Abbafati, JFM van Boven, AD Lopez, ... The Lancet 390 (10100), 1151-1210, 2017 | 4887 | 2017 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3847 | 2018 |
| Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 JB Soriano, PJ Kendrick, KR Paulson, V Gupta, EM Abrams, RA Adedoyin, ... The Lancet Respiratory Medicine 8 (6), 585-596, 2020 | 1410 | 2020 |
| Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990 … JB Soriano, AA Abajobir, KH Abate, SF Abera, A Agrawal, MB Ahmed, ... The Lancet Respiratory Medicine 5 (9), 691-706, 2017 | 934 | 2017 |
| Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 754 | 2018 |
| Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries … AY Chang, K Cowling, AE Micah, A Chapin, CS Chen, G Ikilezi, N Sadat, ... The Lancet 393 (10187), 2233-2260, 2019 | 334 | 2019 |
| Clinical and economic impact of non-adherence in COPD: a systematic review JFM van Boven, NH Chavannes, T van der Molen, ... Respiratory medicine 108 (1), 103-113, 2014 | 268 | 2014 |
| Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ... Nature 574 (7778), 353-358, 2019 | 257 | 2019 |
| Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy BJH Dierick, T van der Molen, BMJ Flokstra-de Blok, A Muraro, ... Expert review of pharmacoeconomics & outcomes research 20 (5), 437-453, 2020 | 219 | 2020 |
| Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial ML Duiverman, JM Vonk, G Bladder, JP van Melle, J Nieuwenhuis, ... Thorax 75 (3), 244-252, 2020 | 171 | 2020 |
| Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review SL Klijn, M Hiligsmann, SMAA Evers, M Roman-Rodriguez, ... NPJ primary care respiratory medicine 27 (1), 24, 2017 | 166 | 2017 |
| Benefits and harm of systemic steroids for short-and long-term use in rhinitis and rhinosinusitis: an EAACI position paper V Hox, E Lourijsen, A Jordens, K Aasbjerg, I Agache, I Alobid, C Bachert, ... Clinical and translational allergy 10, 1-27, 2020 | 154 | 2020 |
| Prevalence and etiology of community-acquired pneumonia in immunocompromised patients MF Di Pasquale, G Sotgiu, A Gramegna, D Radovanovic, S Terraneo, ... Clinical Infectious Diseases 68 (9), 1482-1493, 2019 | 153 | 2019 |
| Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD JAM Westerik, EI Metting, JFM van Boven, W Tiersma, JWH Kocks, ... Respiratory research 18, 1-17, 2017 | 153 | 2017 |
| Comorbidome, pattern and impact of asthma-COPD overlap syndrome in real-life JFM van Boven, M Román-Rodríguez, JF Palmer, NT Pons, BG Cosío, ... CHEST Journal 149 (4), 1011-1020, 2016 | 150 | 2016 |
| What we mean when we talk about adherence in respiratory medicine B Vrijens, AL Dima, E Van Ganse, JFM van Boven, MN Eakin, JM Foster, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (5), 802-812, 2016 | 144 | 2016 |
| Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, ... The Lancet Infectious diseases 16 (12), 1364-1376, 2016 | 139 | 2016 |
| Economic evaluations of pharmacogenetic and pharmacogenomic screening tests: a systematic review. Second update of the literature EJJ Berm, M Looff, B Wilffert, C Boersma, L Annemans, S Vegter, ... PloS one 11 (1), e0146262, 2016 | 125 | 2016 |
Maarten PostmaProfessor in PharmacoEonomicsVerified email at rug.nl
